{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:55:23Z","timestamp":1793850923571,"version":"4.6.1"},"reference-count":47,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"publisher","award":["PI20\/00505"],"award-info":[{"award-number":["PI20\/00505"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"intensification research program","award":["INT21\/00078"],"award-info":[{"award-number":["INT21\/00078"]}]},{"name":"PFIS predoctoral fellowship","award":["FI21\/00003"],"award-info":[{"award-number":["FI21\/00003"]}]},{"name":"Stop Fuga de Cerebros"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miguel Servet Type I","award":["CP19\/00098"],"award-info":[{"award-number":["CP19\/00098"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is characterized by the intracellular lipid accumulation in hepatocytes. Excess caloric intake and high-fat diets are considered to significantly contribute to MASLD development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the hepatic and serum fatty acid (FA) composition in patients with different stages of MASLD, and their relationship with FA dietary intake and MASLD-related risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a case\u2013control study in patients with obesity undergoing bariatric surgery at a university hospital between January 2020 and December 2021. Participants were distributed in 3 groups: no MASLD (n = 26), steatotic liver disease (n = 33), and metabolic dysfunction\u2013associated steatohepatitis (n = 32). Hepatic and serum FA levels were determined by gas chromatography-mass spectrometry. Nutritional status was evaluated using validated food frequency questionnaires. The hepatic expression of genes involved in FA metabolism was analyzed by reverse transcription quantitative polymerase chain reaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The hepatic, but not serum, FA profiles were significantly altered in patients with MASLD compared with those without MASLD. No differences were observed in FA intake between the groups. Levels of C16:0, C18:1, and the C18:1\/C18:0 ratio were higher, while C18:0 levels and C18:0\/C16:0 ratio were lower in patients with MASLD, being significantly different between the 3 groups. Hepatic FA levels and ratios correlated with histopathological diagnosis and other MASLD-related parameters. The expression of genes involved in the FA metabolism was upregulated in patients with MASLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Alterations in hepatic FA levels in MASLD patients were due to enhancement of de novo lipogenesis in the liver.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae028","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:32:28Z","timestamp":1705170748000},"page":"1781-1792","source":"Crossref","is-referenced-by-count":28,"title":["Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity"],"prefix":"10.1210","volume":"109","author":[{"given":"Mar\u00eda \u00c1ngeles","family":"N\u00fa\u00f1ez-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Antonia","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Mart\u00ednez-Montoro","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Biomedical Research Institute of Malaga (IBIMA), Faculty of Medicine, University of Malaga , 29010 Malaga , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Balaguer-Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"},{"name":"Department of General and Digestive System Surgery, Virgen de la Arrixaca University Hospital , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Murcia-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Eating Disorders Research Unit, Faculty of Nursing, UCAM Catholic University of Murcia , 30107 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Esperanza","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"},{"name":"Department of Endocrinology and Nutrition, Virgen de la Arrixaca University Hospital , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Ferrer-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"},{"name":"Department of Endocrinology and Nutrition, Virgen de la Arrixaca University Hospital , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Manuel","family":"Mart\u00ednez-C\u00e1ceres","sequence":"additional","affiliation":[{"name":"Experimental Pathology Service, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Sledzinski","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk , 80-211 Gdansk , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Frutos","sequence":"additional","affiliation":[{"name":"Department of General and Digestive System Surgery, Virgen de la Arrixaca University Hospital , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Hern\u00e1ndez-Morante","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"},{"name":"Eating Disorders Research Unit, Faculty of Nursing, UCAM Catholic University of Murcia , 30107 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Regional University Hospital of Malaga, Biomedical Research Institute of Malaga (IBIMA), Faculty of Medicine, University of Malaga , 29010 Malaga , Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de la Fisiopatolog\u00eda de la Obesidad y la Nutrici\u00f3n (CIBERObn), Instituto de Salud Carlos III , 28029 Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Queipo-Ortu\u00f1o","sequence":"additional","affiliation":[{"name":"Intercenter Medical Oncology Clinical Management Unit, Regional and Virgen de la Victoria University Hospitals, M\u00e1laga Biomedical Research Institute (IBIMA)-CIMES-UMA , 29010 M\u00e1laga , Spain"},{"name":"Department of Surgical Specialties, Biochemical and Immunology. Faculty of Medicine, University of M\u00e1laga , 29071 Malaga , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jos\u00e9","family":"Ruiz-Alcaraz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology B and Immunology, Faculty of Medicine, University of Murcia , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-5652","authenticated-orcid":false,"given":"Adriana","family":"Mika","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk , 80-211 Gdansk , Poland"},{"name":"Department of Environmental Analysis, Faculty of Chemistry, University of Gdansk , 80-211 Gdansk , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-5449","authenticated-orcid":false,"given":"Bruno","family":"Ramos-Molina","sequence":"additional","affiliation":[{"name":"Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB) , 30120 Murcia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"key":"2024061623521951200_dgae028-B1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"2024061623521951200_dgae028-B2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"2024061623521951200_dgae028-B3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed Nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"2024061623521951200_dgae028-B4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2024061623521951200_dgae028-B5","doi-asserted-by":"crossref","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2024061623521951200_dgae028-B6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"2","key":"2024061623521951200_dgae028-B7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/jcm10020346","article-title":"Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study","volume":"10","author":"Tarantino","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"2024061623521951200_dgae028-B8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"2024061623521951200_dgae028-B9","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2024061623521951200_dgae028-B10","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.3390\/ijms22136900","article-title":"The role of fatty acids in non-alcoholic fatty liver disease progression: an update","volume":"22","author":"Hliwa","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2024061623521951200_dgae028-B11","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1111\/liv.15059","article-title":"The role of hepatic lipid composition in obesity-related metabolic disease","volume":"41","author":"Willis","year":"2021","journal-title":"Liver Int"},{"issue":"8","key":"2024061623521951200_dgae028-B12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/antiox12081554","article-title":"Plasma fatty acid composition, oxidative and inflammatory Status, and adherence to the Mediterranean diet of patients with non-alcoholic fatty liver disease","volume":"12","author":"Monserrat-Mesquida","year":"2023","journal-title":"Antioxidants"},{"issue":"18","key":"2024061623521951200_dgae028-B13","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"2024061623521951200_dgae028-B14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jcmgh.2019.02.001","article-title":"Macronutrients and the adipose-liver axis in obesity and fatty liver","volume":"7","author":"Duwaerts","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2024061623521951200_dgae028-B15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3748\/wjg.v21.i1.301","article-title":"Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease","volume":"21","author":"Maciejewska","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2024061623521951200_dgae028-B16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n\u20146\/n\u20143 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin Sci (Lond"},{"issue":"3","key":"2024061623521951200_dgae028-B17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/nu11030677","article-title":"Impact of nutritional changes on nonalcoholic fatty liver disease","volume":"11","author":"Perdomo","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"2024061623521951200_dgae028-B18","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3945\/jn.110.125732","article-title":"Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation","volume":"140","author":"Kalupahana","year":"2010","journal-title":"J Nutr"},{"issue":"5","key":"2024061623521951200_dgae028-B19","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"2024061623521951200_dgae028-B20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.soard.2022.12.041","article-title":"Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity","volume":"19","author":"Martinez-Sanchez","year":"2023","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"2024061623521951200_dgae028-B21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"2024061623521951200_dgae028-B22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/22.3.512","article-title":"Development and validation of a food frequency questionnaire in Spain","volume":"22","author":"Martin-Moreno","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"3","key":"2024061623521951200_dgae028-B23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/oby.2008.466","article-title":"N-6 from different sources protect from metabolic alterations to obese patients: a factor analysis","volume":"17","author":"Hernandez-Morante","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"2024061623521951200_dgae028-B24","volume-title":"Tablas de Composici\u00f3n de Alimentos Espa\u00f1oles","author":"Mataix","year":"1998"},{"issue":"1","key":"2024061623521951200_dgae028-B25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"issue":"4","key":"2024061623521951200_dgae028-B26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/oby.23711","article-title":"Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: a case-control study","volume":"31","author":"Martinez-Montoro","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"2024061623521951200_dgae028-B27","doi-asserted-by":"crossref","unstructured":"N\u00fa\u00f1ez-S\u00e1nchez MA, Mart\u00ednez-S\u00e1nchez MA, Mart\u00ednez-Montoro JI, et al Supplementary Material from Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity. ZENODO. 2024. https:\/\/zenodo.org\/records\/10448497.","DOI":"10.1210\/clinem\/dgae028"},{"issue":"5","key":"2024061623521951200_dgae028-B28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.aohep.2020.06.008","article-title":"Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients","volume":"19","author":"L\u00f3pez-Bautista","year":"2020","journal-title":"Ann Hepatol"},{"issue":"6","key":"2024061623521951200_dgae028-B29","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"2024061623521951200_dgae028-B30","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/biomedicines10102540","article-title":"Plasma fatty acid composition is associated with histological findings of nonalcoholic steatohepatitis","volume":"10","author":"Miyake","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"2024061623521951200_dgae028-B31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J Hepatol"},{"issue":"10","key":"2024061623521951200_dgae028-B32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.ebiom.2015.09.004","article-title":"Circulating unsaturated fatty acids delineate the metabolic Status of obese individuals","volume":"2","author":"Ni","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"2024061623521951200_dgae028-B33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S0007114515004341","article-title":"Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans","volume":"115","author":"Sergeant","year":"2016","journal-title":"Br J Nutr"},{"issue":"4","key":"2024061623521951200_dgae028-B34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"2024061623521951200_dgae028-B35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2007.08.005","article-title":"Omega 3\u2014omega 6: what is right for the liver?","volume":"47","author":"El-Badry","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"2024061623521951200_dgae028-B36","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"2024061623521951200_dgae028-B37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3945\/ajcn.114.092262","article-title":"Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis","volume":"101","author":"Lee","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2024061623521951200_dgae028-B38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case\u2014control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"2024061623521951200_dgae028-B39","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"2024061623521951200_dgae028-B40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/liv.12685","article-title":"Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis","volume":"35","author":"Yamada","year":"2015","journal-title":"Liver Int"},{"issue":"10","key":"2024061623521951200_dgae028-B41","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/jgh.14654","article-title":"Serum C16:1n7\/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis","volume":"34","author":"Yamada","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2024061623521951200_dgae028-B42","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-020-15684-0","article-title":"Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance","volume":"11","author":"Roumans","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2024061623521951200_dgae028-B43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"issue":"6","key":"2024061623521951200_dgae028-B44","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"Matsuzaka","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"2024061623521951200_dgae028-B45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4254\/wjh.v14.i1.168","article-title":"Stearoyl-CoA desaturase 1: a potential target for non-alcoholic fatty liver disease? -perspective on emerging experimental evidence","volume":"14","author":"Jeyakumar","year":"2022","journal-title":"World J Hepatol"},{"issue":"4","key":"2024061623521951200_dgae028-B46","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1172\/JCI200523962","article-title":"Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1","volume":"115","author":"Jiang","year":"2005","journal-title":"J Clin Invest"},{"key":"2024061623521951200_dgae028-B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.08.001","article-title":"Role of DGAT enzymes in triacylglycerol metabolism","volume":"655","author":"Bhatt-Wessel","year":"2018","journal-title":"Arch Biochem Biophys"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae028\/56549506\/dgae028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1781\/58235443\/dgae028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/7\/1781\/58235443\/dgae028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T23:53:11Z","timestamp":1718581991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/7\/1781\/7529177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,1,13]]},"published-print":{"date-parts":[[2024,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae028","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,1,13]]}}}